ClinConnect ClinConnect Logo
Search / Trial NCT07052331

The MOBY Study: Efficacy of Birth Mobility

Launched by VIBWIFE AG · Jun 26, 2025

Trial Information

Current as of July 12, 2025

Not yet recruiting

Keywords

Birth Mobility Maternal Satisfaction Labor And Delivery Neonatal Outcomes

ClinConnect Summary

This clinical trial, called the MOBY Study, is looking at how moving around during labor affects the birth experience and outcomes for first-time mothers. The researchers want to find out if using a special system that encourages mobility during labor can help lower the chances of needing a cesarean section (C-section). They will also check how labor progresses, the use of pain medication, the health of the newborn, and how satisfied mothers feel about their birth experience.

Women who are at least 18 years old, expecting their first baby, carrying one baby in the head-down position, and who speak German or English may be eligible to join. Participants need to have a low-risk pregnancy and be ready to deliver after 37 weeks. During the study, mothers will receive either the usual care or care that includes the birth mobility system, and routine information about their labor and delivery will be collected. After birth, they will be asked to complete a short questionnaire about their experience. It’s important to know that this study is not yet recruiting participants, and women with certain health conditions or pregnancy complications won’t be able to join.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • German- or English-speaking
  • Able to provide written informed consent with capacity of judgment
  • Low-risk singleton pregnancy
  • Primiparous woman
  • Cephalic presentation
  • Gestational age at delivery ≥ 37 + 0 weeks
  • Exclusion Criteria:
  • Multiparous woman
  • Not capable of understanding instructions for use of the mobility system (intervention group)
  • Scheduled (elective) cesarean section
  • Contraindication to vaginal delivery
  • Multiple pregnancy
  • Breech presentation
  • Estimated fetal weight \< 10th percentile or \> 90th percentile
  • Relevant fetal congenital abnormalities affecting neonatal adaptation
  • Pre-existing medical conditions significantly affecting mobility (e.g., orthopedic conditions, osteoporosis, multiple sclerosis, spinal cord injury)
  • Relevant intrapartum bleeding
  • Preeclampsia or HELLP syndrome

About Vibwife Ag

Vibwife AG is a clinical research organization dedicated to advancing medical innovation through the development and management of high-quality clinical trials. Committed to scientific excellence and patient safety, Vibwife AG collaborates closely with healthcare professionals, academic institutions, and industry partners to facilitate the efficient evaluation of new therapies and medical devices. Their expertise spans a range of therapeutic areas, emphasizing rigorous study design, regulatory compliance, and data integrity to support the successful translation of research into improved patient outcomes.

Locations

Baden, Aargau, Switzerland

Patients applied

0 patients applied

Trial Officials

Prof. Dr. med. Leonhard Schäffer

Principal Investigator

Kantonsspital Baden

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported